Chief Medical Officer
Philip J. Bergman, DVM, MS, PhD
Dr. Bergman is one of the nation’s leading veterinary oncologists, having developed a canine melanoma vaccine that was granted full licensure by the U.S. Department of Agriculture in December of 2009, the first U.S. government-approved vaccine of any kind for the treatment of cancer. Dr. Bergman previously completed a Ph.D. in human cancer biology from the M.D. Anderson Cancer Center and was the head of the Donaldson-Atwood Cancer Clinic at the Animal Medical Center for 8 years.
He is currently the Immediate Past Chair of the American College of Veterinary Internal Medicine and continues his cancer vaccine work at BrightHeart, seeking to extend its applicability to canine lymphoma, breast cancer and other tumors. While Dr. Bergman serves the entire BrightHeart organization as Chief Medical Officer with oversight of each facility’s medical practices and performance, he is also available for individual cases at KBVC.
